ArticleCureus2025
Successful Management of Rapidly Progressive Interstitial Pneumonia With Autoimmune Features in an Elderly Patient: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An 82-year-old man presented with acute respiratory distress, a one-week history of dry cough, and worsening dyspnea. Chest computed tomography revealed bilateral diffuse ground-glass opacities, raising suspicion of rapidly progressive interstitial pneumonia. Rapid autoantibody testing confirmed interstitial pneumonia with autoimmune features (IPAF), likely triggered by an upper respiratory infection. Initial treatment with high-dose steroid pulse therapy was insufficient to stabilize the patient's respiratory status. Cyclophosphamide pulse therapy was initiated on day 4, resulting in significant improvement by day 7. The patient's oxygen requirements steadily decreased, and follow-up imaging showed near-complete resolution of lung abnormalities. Intensive immunosuppressive therapy, infection control measures, and tailored supportive care enabled functional recovery and discharge to a rehabilitation facility. This case highlights the importance of early diagnosis, rapid immunological evaluation, and aggressive immunosuppressive therapy in managing rapidly progressive interstitial pneumonia in elderly patients. Individualized treatment plans based on overall health rather than biological age can significantly improve outcomes, even in critically ill elderly patients. Early initiation of multidisciplinary care is crucial to achieving remission and restoring quality of life in this challenging population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.